What is American Bio Medica Corporation (ABMC)?

American Bio Medica Corporation (ABMC) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

What is the current price of ABMC?

The current price of ABMC is $0.00. Prices are updated in real time on Stocks360.

What is ABMC's price-to-earnings (PE) ratio?

ABMC's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is ABMC's market capitalization?

ABMC's market capitalization is $4,810.00, placing it in the small-cap tier.

American Bio Medica Corporation (ABMC)

Stock analysis · OTC · Healthcare · Medical - Diagnostics & Research

$0.00

Market Cap

$4.81K

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-0.12

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

2.40K

American Bio Medica Corporation (ABMC) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $4.81K. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

Proprietary Signals

Signal snapshot temporarily unavailable.

About American Bio Medica Corporation

American Bio Medica Corporation (ABMC) specializes in the development and distribution of lateral flow immunoassay tests, primarily designed for the rapid detection of drugs in both urine and oral fluid samples. Their extensive range of urine-based drug screening solutions includes the Rapid Drug Screen, capable of identifying between 2 and 10 substances; the RDS InCup, a convenient testing cup detecting 1 to 12 drugs; Rapid TOX, a cassette-based test for 1 to 10 drugs; and the Rapid TOX Cup II, another cup format that screens for 1 to 16 different drugs. Each product aims to swiftly determine the presence or absence of illicit substances. Furthermore, ABMC provides OralStat, an oral fluid drug test, available also in private-labeled versions. Beyond its proprietary offerings, the company acts as a distributor for various other products focused on detecting substances of abuse and identifying specific infectious diseases. The company extends its expertise to non-affiliated diagnostic firms, offering contract services that encompass the manufacturing, assembly, and packaging of diagnostic strips. Serving a diverse clientele, ABMC caters to the needs of rehabilitation and drug treat…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	0.01×
P/B	-0.00×
PEG	0.00×
P/FCF (TTM)	-0.01×
EV / EBITDA	-1.90×
EV / Sales	2.42×
Earnings Yield	-29364.20%
Free Cash Flow Yield	-15966.74%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$2.21M
Revenue (TTM)	$913.00K
Net Income (TTM)	-$1.41M
Free Cash Flow (TTM)	-$573.72K
Net Debt	$2.21M
Working Capital	-$2.83M
Gross Margin	-21.14%
Operating Margin	-136.04%
Net Margin	-154.44%
Return on Equity	85.90%
Return on Invested Capital	1254.55%